This inventor holds 3 USPTO granted patents. Top assignees: Delalande S.a., Delande S.a.. Active years: 1990-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-1994
Title: **Innovator Spotlight: Maryse F. Masson**
Introduction
Maryse F. Masson, based in Paris, France, is a distinguished inventor known for her contributions in the field of pharmaceuticals. With a total of three patents to her name, she has made significant strides in developing innovative therapeutic compounds that have the potential to impact healthcare positively.
Latest Patents
Maryse's latest patents focus on derivatives of 4-(hetero)arylmethyloxy phenyl diazole. These compounds are characterized by having the formula where R₁ is a C₁-C₄ alkyl group and Ar can be either an aryl or heteroaryl group. Notably, these derivatives serve as crucial agents in inhibiting type B monoamine oxidase, offering promising applications in therapeutic treatments.
Career Highlights
Throughout her career, Maryse has been associated with Delalande S.A., where she honed her skills and applied her innovative ideas to real-world applications. Her dedication to research and development has led to significant advancements in her field.
Collaborations
Maryse has worked alongside esteemed colleagues, including Jean-Jacques Koenig and Luc L. Lebreton. These collaborations have fostered a dynamic exchange of knowledge and ideas, contributing to the success of her innovative projects.
Conclusion
Maryse F. Masson's work exemplifies the impact of innovation in pharmaceutical research. Her ongoing contributions through her patents continue to pave the way for advancements in therapy, highlighting the crucial role of dedicated inventors in enhancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile